ShenZhen New Industries Biomedical Engineering News

New industry (300832): Net profit due to mother increased 20% year-on-year in the first quarter of 2024, and overseas business grew rapidly

國信證券May 15 23:51

New industry (300832): excellent performance, increasing the share of overseas medium and large machines, rapid growth in reagents

天風證券May 6 00:46

New industry (300832): Performance is in line with expectations, high speed machine installation+reagent release drive increase in profit level

方正證券Apr 29 18:46

New industry (300832): Mainframe share increased, overseas growth maintained rapid growth

國泰君安Apr 28 05:21

New industry (300832): 1Q24 results are in line with expectations, gross margin increased year-on-year

中金公司Apr 28 00:36

New Industries (300832) 2024 Quarterly Report Review: Continued High Growth Overseas Reagent Business Share Increased

華創證券Apr 27 11:00

New industries (300832): First-quarter results are in line with expectations, maintaining good overseas growth

銀河證券Apr 26 11:00

Nomura Adjusts Shenzhen New Industries Biomedical Engineering's Price Target to 93.36 Yuan From 98.15 Yuan, Keeps at Buy

MT NewswiresApr 26 03:55

New industry (300832): rapid 1Q profit growth and continued improvement in profitability

華泰證券Apr 24 11:00

New industry (300832): Continued growth in business performance and steady increase in profitability

海通證券Apr 23 07:16

New industry (300832): 2023 revenue increased 29% year-on-year, rapid release of overseas reagent revenue

國信證券Apr 22 02:36

Guoxin Securities released a research report on April 22 stating that it gave the new industry (300832.SZ) a purchase rating. The main reasons for the rating include: 1) the overseas growth rate is faster than domestic revenue, and the installed structure

Zhitong FinanceApr 22 01:32

Dongwu Securities released a research report on April 18 stating that it gave the new industry (300832.SZ) a buying rating. The main reasons for the rating include: 1) Q4 will maintain a high growth rate and increase in profitability; 2) domestic business

Zhitong FinanceApr 18 03:45

Huafu Securities released a research report on April 16 stating that the new industry (300832.SZ) was given a purchase rating, and the target price was 80.09 yuan. The main reasons for the rating include: 1) the company released its 2023 annual report, an

Zhitong FinanceApr 16 01:26

New industry (300832): 23 years of steady growth in performance, achieving new breakthroughs in medium and large overseas installations

光大證券Apr 15 18:36

Southwest Securities released a research report on April 15 stating that it gave the new industry (300832.SZ) a buying rating. The main reasons for the rating include: 1) maintaining rapid growth in 2023 performance; 2) domestic: continuing to promote hig

Zhitong FinanceApr 15 06:41

New industry (300832): The company's performance is in line with expectations, and the increase in the share of medium and mainframe computers drives steady growth in domestic and foreign performance

方正證券Apr 15 01:21

Zhongtai Securities released a research report on April 15 stating that it gave the new industry (300832.SZ) a buying rating. The main reasons for the rating include: 1) the share of high-end light-emitting equipment has increased, and the gross margin le

Zhitong FinanceApr 14 19:38

New industry (300832): Performance is in line with expectations, domestic and foreign business continues to grow rapidly

銀河證券Apr 13 18:46

New Industries (300832) 2023 Report Review: Continued High Overseas Growth and Steady Increase in Gross Margin

華創證券Apr 13 11:00